Prostaglandin analogs in ulcer therapy
Hotz, J.
Zeitschrift für Gastroenterologie. Verhandlungsband 26: 162-165
1991
ISSN/ISBN: 0172-8504 PMID: 1714135 Document Number: 378576
Document emailed within 1 workday
Related Documents
Stefan, C.; Nenciu, A.; Malcea, C.; Tebeanu, E. 2005: Axial length of the ocular globe and hypotensive effect in glaucoma therapy with prostaglandin analogs Oftalmologia 49(4): 47-50Zhukova, T.A.; Chaialo, P.P.; Kutsenok, V.A.; Iakovlev, A.A.; Rozhavin, M.A.; Sologub, V.V.; Chaĭka, M.V. 1990: State of the prostaglandin and cyclic nucleotide system in microwave resonance therapy of peptic ulcer Klinicheskaia Meditsina 68(3): 99-101
Petac, D.; Schilling, E.; Smidt, D. 1978: Cycle synchronization in heifers using prostaglandin analogs Berliner und Munchener Tierarztliche Wochenschrift 91(24): 473-475
Nylander, B.; Andersson, S. 1975: Effect of two methylated prostaglandin E2 analogs on gastroduodenal pressure in man Scandinavian Journal of Gastroenterology 10(1): 91-95
Pathanapitoon, K.; Kunavisarut, P. 2005: Choroidal detachment after topical prostaglandin analogs: case report Journal of the Medical Association of Thailand 88(8): 1134-1136
Petrukhina, G.N.; Makarov, V.A. 1995: Possible aspects of the use of prostacyclin, prostaglandin E1 and their synthetic analogs in medical practice Eksperimental'naia i Klinicheskaia Farmakologiia 58(3): 70-79
Weiler, H.; Weiler, C.; Gerok, W. 1990: Gastric mucosal prostaglandin E2 levels in gastric non-ulcer and ulcer patients with chronic renal failure or without renal disease, and in healthy subjects Netherlands Journal of Medicine 37(5-6): 189-196
Sharif, N.A.; Xu, S.X.; Williams, G.W.; Crider, J.Y.; Griffin, B.W.; Davis, T.L. 1998: Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data Journal of Pharmacology and Experimental Therapeutics 286(2): 1094-1102
Watanabe, K.; Iguchi, Y.; Iguchi, S.; Arai, Y.; Hayaishi, O.; Roberts, L.J. 1986: Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase Proceedings of the National Academy of Sciences of the United States of America 83(6): 1583-1587
Kerekes, L.; Domokos, N. 1975: Labor induction with prostaglandin F2-alpha and oxytocin, accompanied by membrane rupturing as well as supportive prostaglandin F2-alpha therapy (comparative study) Orvosi Hetilap 116(48): 2833-2836
Grigor'ev, P.Ia.; Isakov, V.A. 1991: Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer Sovetskaia Meditsina 1991(3): 39-43
Levine, B.A.; Sirinek, K.R. 1987: The physiology of postvagotomy duodenal ulcer healing: a prostaglandin connection Surgery 102(4): 587-594
Roost, R.; Wright, J.P.; Young, G.O.; Lipshitz, E.M.; Klaff, L.; Isaacs, S.; Marks, I.N. 1986: The effect of aspirin and anti-ulcer drugs on gastric mucosal prostaglandin e South African Medical Journal 70(10): 594-597
Loginov, A.S.; Zverkov, I.V.; Kondashova, Z.D.; Sokolova, G.N.; Minushkin, O.N. 1992: The treatment of patients with duodenal peptic ulcer with a synthetic prostaglandin E2 analog (enprostil) Terapevticheskii Arkhiv 64(8): 77-79
Petersen, H.D.; Bonnevie, O.; Jacobsen, P.; Matzen, P.; Mikkelsen, A.G.; Mosbech, J.; Munkgaard, S.; Vadstrup, S.; Wandall, J.H. 1987: Prostaglandin E1 (misoprostol) versus cimetidine in the treatment of duodenal ulcer. a controlled clinical trial Ugeskrift for Laeger 149(15): 969-971
Feifel, G.; Koller, H. 1982: Ulcer recurrence after surgical therapy of duodenal ulcer Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 53(1): 23-28
Vantrappen, G.; Janssens, J.; Popiela, T.; Kulig, J.; Tytgat, G.N.; Huibregtse, K.; Lambert, R.; Pauchard, J.P.; Robert, A. 1982: Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study Gastroenterology 83(2): 357-363
Okada, S.; Miyai, Y.; Sato, K.; Higuchi, T.; Ichiki, K.; Tanokuchi, S.; Ishii, K.; Hamada, H.; Ota, Z. 1991: Decreased creatinine clearance which may be observed during prostaglandin E1 therapy: is it reversible with discontinuation of therapy? Journal of International Medical Research 19(6): 493-496
Eremina, E.I. 1992: The characteristics of prostaglandin and cyclic nucleotide biosynthesis in patients with peptic ulcer and chronic atrophic gastritis during digestion Likars'ka Sprava 9: 24-27
1983: Pathogenesis, diagnosis and therapy of ulcer diseases. 6. Therapy. Pharmacologic principles and antacid therapy Die Medizinische Welt 34(47): 14-18